Expansion of U.S. Testing using coordination hubs - hubs 3 & 4

Ended Other Transaction Agreement Awarded Last action

Contract number
W52P1J2192000
Awardee
Awarding agency
Obligated
$100,278,655

Award facts

Opportunity
Contract value 100% obligated
$100,278,654.69 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other
Place of performance
Framingham, MA 01702, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 · The purpose of modification P00009 is to formally close-out the agreement. $0
Funding Only Action P00008 · The purpose of modification P00008 is to DE-obligate funding. -$85,060,337
Funding Only Action P00007 · DE-obligation of testing clins -$89,523,839
Supplemental Agreement for work within scope P00006 · Update SOW $0
Funding Only Action P00005 · OTA extension modification. POP end date 31 december 2022. $249,980
Funding Only Action P00004 · 10:1 pooled test - hub 3 and 4 -$22
Funding Only Action P00003 · Incorporate alternate testing methods -$9
Funding Only Action P00002 · Modification P00002 is to incorporate government furnished property GFP - CUE tests -$250,000
Other Administrative Action P00001 · Modification is to extend the period of performance end date from 24 november 2021 to 01 july 2022 at no additional cost to the government $0
Original award $274,862,880

About this award

Written by GovTribe AI ·

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $100.3 million other transaction agreement to Clinical Enterprise, Inc. to support the expansion of U.S. testing using coordination hubs 3 and 4. The prime contractor, Clinical Enterprise, Inc., will deliver coordination hub services for COVID-19 testing in Framingham, Massachusetts under the contract, which runs from May 2021 through December 2022. No set aside designation or subcontractors were indicated. The award provides additional resources to the Department of Defense and Army's chemical and biological defense programs for coordinating federally-supported COVID-19 testing nationwide using designated regional hubs during the ongoing public health emergency.

Quick answers

Who was awarded contract W52P1J2192000?

W52P1J2192000 was awarded to Clinical Enterprise, LLC by Department of the Army (Department of Defense) on May 25, 2021.

How much is contract W52P1J2192000 worth?

The government has obligated $100,278,655 on W52P1J2192000.

Which agency awarded contract W52P1J2192000?

Department of the Army (Department of Defense) awarded W52P1J2192000, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W52P1J2192000 competed?

The extent of competition for W52P1J2192000 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login